Filter News
Area of Research
- (-) Isotope Development and Production (1)
- (-) Materials for Computing (1)
- Advanced Manufacturing (3)
- Biology and Environment (4)
- Clean Energy (16)
- Computer Science (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (27)
- Fusion Energy (10)
- Isotopes (25)
- Materials (32)
- National Security (23)
- Neutron Science (4)
- Nuclear Science and Technology (38)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (2)
- Supercomputing (13)
News Type
News Topics
- (-) Isotopes (1)
- (-) Nuclear Energy (1)
- 3-D Printing/Advanced Manufacturing (4)
- Bioenergy (1)
- Biology (1)
- Biomedical (2)
- Chemical Sciences (4)
- Climate Change (1)
- Composites (1)
- Computer Science (7)
- Coronavirus (3)
- Decarbonization (1)
- Energy Storage (4)
- Environment (1)
- Irradiation (1)
- Materials (10)
- Materials Science (16)
- Microscopy (4)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (5)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (3)
- Security (1)
- Simulation (1)
- Space Exploration (2)
- Summit (1)
- Sustainable Energy (5)
- Transportation (5)
Media Contacts
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.